NOVAVAX INC

NVAX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
315
SEC Filings

Business Summary

PART I Overview Novavax, Inc., together with our wholly owned subsidiaries, tackles some of the worlds most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M adjuvant and protein-based nanoparticles. Our corporate growth strategy focuses on maximizing the impact of our cutting-edge technology by forging partnerships for our Matrix-M adjuvant and research and development (R&D) assets while maintaining a lean and focused...

Next Earnings

Q2 FY2026 — expected 2026-08-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNVAXdiscussed_in_filing Cybersecurity
topic_mentionNVAXdiscussed_in_filing Trusted Computing
topic_mentionNVAXdiscussed_in_filing Blockchain & Crypto
topic_mentionNVAXdiscussed_in_filing Regulation
topic_mentionNVAXdiscussed_in_filing Healthcare & Bio
topic_mentionNVAXdiscussed_in_filing Platform & Ecosystem
topic_mentionNVAXdiscussed_in_filing Sovereign & Government
topic_mentionNVAXdiscussed_in_filing Cybersecurity
topic_mentionNVAXdiscussed_in_filing Trusted Computing
topic_mentionNVAXdiscussed_in_filing Blockchain & Crypto
topic_mentionNVAXdiscussed_in_filing Regulation
topic_mentionNVAXdiscussed_in_filing Healthcare & Bio
topic_mentionNVAXdiscussed_in_filing Platform & Ecosystem
topic_mentionNVAXdiscussed_in_filing Sovereign & Government
topic_mentionNVAXdiscussed_in_filing Cybersecurity
topic_mentionNVAXdiscussed_in_filing Trusted Computing
topic_mentionNVAXdiscussed_in_filing Blockchain & Crypto
topic_mentionNVAXdiscussed_in_filing Regulation
topic_mentionNVAXdiscussed_in_filing Healthcare & Bio
topic_mentionNVAXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001000694-26-000007EDGAR92K words
2025-02-272024-12-310001000694-25-000004EDGAR
2024-02-282023-12-310001000694-24-000007EDGAR
2023-02-282022-12-310001000694-23-000005EDGAR
2022-03-012021-12-310001000694-22-000004EDGAR
2021-03-012020-12-310001000694-21-000004EDGAR
2020-03-112019-12-310001104659-20-031944EDGAR
2019-03-182018-12-310001144204-19-014640EDGAR
2018-03-142017-12-310001144204-18-014686EDGAR
2017-02-272016-12-310001144204-17-011334EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001000694-25-000046EDGAR32K words
2025-08-062025-06-300001000694-25-000029EDGAR
2025-05-082025-03-310001000694-25-000021EDGAR
2024-11-122024-09-300001000694-24-000043EDGAR
2024-08-082024-06-300001000694-24-000035EDGAR
2024-05-102024-03-310001000694-24-000031EDGAR
2023-11-092023-09-300001000694-23-000055EDGAR
2023-08-082023-06-300001000694-23-000047EDGAR
2023-05-092023-03-310001000694-23-000040EDGAR
2022-11-092022-09-300001000694-22-000024EDGAR
2022-08-092022-06-300001000694-22-000016EDGAR
2022-05-102022-03-310001000694-22-000009EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001000694-26-000011EDGAR5K words
2026-01-200001104659-26-004785EDGAR
2026-01-120001104659-26-002725EDGAR
2025-11-060001000694-25-000048EDGAR
2025-11-040001104659-25-105818EDGAR
2025-10-220001104659-25-101390EDGAR
2025-10-070001104659-25-097317EDGAR
2025-08-270001104659-25-084053EDGAR
2025-08-270001104659-25-084049EDGAR
2025-08-210001104659-25-081160EDGAR

315 total filings indexed. 283 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001000694
TickerNVAX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a017d1825cafc907efc40aed7b84151030ac952e5519c81288853e987de26f65
parent: 0e3af100c093e3f6224b17cb244dbe508230d41b0410b2d354131457a6b0ebf1
content hash: 90349fcdceadefd314a2444a8e4d6d04642be1af79a37f27af3795bdab3a9c2b
signed: 2026-04-13T04:46:37.371Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf